MyFinsight
Home
Blog
About
Back
Income Statement
Marker Therapeutics, Inc. (MRKR)
Marker Therapeutics, Inc. (MRKR)
source: myfinsight.com
Net loss
-$1,826,229
(54.52%↑ Y/Y)
Grant income
$681,579
Interest income
$112,558
(-12.08%↓ Y/Y)
Loss from operations
-$2,620,366
(38.50%↑ Y/Y)
Total operating
expenses
$2,620,366
(-48.84%↓ Y/Y)
Research and development
$1,476,161
(-64.66%↓ Y/Y)
General and
administrative
$1,144,205
(21.06%↑ Y/Y)
Back